Skip to main content

Together we are beating cancer

Donate now

Lymphoma

Showing 12 out of 89 results

We explore the promise and challenges of research looking to engineer patients' immune cells to fight cancer. We explore the promise and challenges of research looking to engineer patients' immune cells to fight cancer.

by Laura Mears | Analysis | 19 January 2016

19 January 2016

We explore the second of our Grand Challenges and ask the experts if we can wipe out cancers caused by the Epstein-Barr Virus. We explore the second of our Grand Challenges and ask the experts if we can wipe out cancers caused by the Epstein-Barr Virus.

by Emma Smith | Analysis | 10 December 2015

10 December 2015

In the latest Our Milestones series post, we look at the role we played in the advent of a 1970s cancer treatment revolution: combination chemotherapy. In the latest Our Milestones series post, we look at the role we played in the advent of a 1970s cancer treatment revolution: combination chemotherapy.

by Aine McCarthy | Analysis | 24 March 2015

24 March 2015

This entry is part 21 of 30 in the series Our milestones
Richard Stephens

A personal take on the findings of the National Cancer Patient Experience Survey from Richard Stephens, who survived Hodgkin’s lymphoma 15 years ago. A personal take on the findings of the National Cancer Patient Experience Survey from Richard Stephens, who survived Hodgkin’s lymphoma 15 years ago.

by Richard Stephens | Analysis | 6 February 2015

6 February 2015

Researcher in the lab

Cancer Research UK, Cancer Research Technology and Leukaemia & Lymphoma Research to trial BioInvent's antibody drug for non-Hodgkin lymphoma. Cancer Research UK, Cancer Research Technology and Leukaemia & Lymphoma Research to trial BioInvent's antibody drug for non-Hodgkin lymphoma.

by Cancer Research Technology (CRT) | News | 20 January 2015

20 January 2015

  • Science & Technology
  • Health & Medicine

NCRI 2014 conference summary - day 1

Here's our round up from day one of the NCRI cancer conference in Liverpool Here's our round up from day one of the NCRI cancer conference in Liverpool

by Henry Scowcroft | Analysis | 3 November 2014

3 November 2014

Cancer Research UK scientists have found that targeting a molecule in blood vessels can make cancer therapy significantly more effective. Cancer Research UK scientists have found that targeting a molecule in blood vessels can make cancer therapy significantly more effective.

by Cancer Research UK | News | 27 July 2014

27 July 2014

Europe at night

Survival rates for people with blood cancer have improved across Europe, but variations still exist from country to country. Survival rates for people with blood cancer have improved across Europe, but variations still exist from country to country.

by In collaboration with PA Media Group | News | 15 July 2014

15 July 2014

Concluding our story on Epstein-Barr virus and cancer, we explore the ongoing research into the virus and how this could lead to treatments in the future. Concluding our story on Epstein-Barr virus and cancer, we explore the ongoing research into the virus and how this could lead to treatments in the future.

by Emma Smith | Analysis | 9 April 2014

9 April 2014

This entry is part 4 of 5 in the series Cancer and Infections

Women who always or mostly eat organic foods are no less likely to develop cancer than women who eat a more conventional diet. Women who always or mostly eat organic foods are no less likely to develop cancer than women who eat a more conventional diet.

by Cancer Research UK | News | 28 March 2014

28 March 2014